EliasHSarkisMD

Psychiatry • Gainesville, FL

Child & Adolescent Psychiatry

Owner at Sarkis Clinical Trials

Join to view full profile

Dr. Sarkis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sarkis' full profile

Already have an account?

Office
529 NW 60th St
Gainesville, FL 32607
Phone+1 352-331-5100

Education & Training

University of FloridaFellowship, Child and Adolescent Psychiatry, 1989 - 1991
University of FloridaResidency, Psychiatry, 1986 - 1989
Faculté de MédecineClass of 1985, MD, Cum Laude

Certifications & Licensure

FL State Medical License 1987 - 2026
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Child & Adolescent Psychiatry

Awards, Honors, & Recognition

Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Pediatric Schizophrenia Efficacy and Safety Study Start of enrollment: 2013 Aug 01
Completed
Phase 3
Lurasidone Pediatric Autism Study Start of enrollment: 2013 Aug 01
Completed
Phase 3
Pediatric Open-Label Extension Study Start of enrollment: 2013 Sep 30
Completed
Phase 3
Lurasidone Pediatric Bipolar Study Start of enrollment: 2014 Mar 01
Completed
Phase 3
PRC-063 in Adolescent ADHD Start of enrollment: 2014 Apr 01
Completed
Phase 3
Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD Start of enrollment: 2014 May 01
Completed
Phase 3
Dasotraline Pediatric ADHD Study Start of enrollment: 2015 Apr 01
Completed
Phase 2, Phase 3
Dasotraline Pediatric Extension Study Start of enrollment: 2015 Jun 30
Completed
Phase 3
Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD) Start of enrollment: 2015 Jun 18
Completed
Phase 3
Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder Start of enrollment: 2015 Jul 27
Completed
Phase 3
A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting Start of enrollment: 2015 Aug 01
Completed
Phase 3
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD) Start of enrollment: 2015 Nov 19
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

178 citations
Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
Anil Gupta, Yaneicy Gonzalez-Rojas, Erick Juarez, Manuel Crespo Casal, Jaynier Moya
JAMA. 2022-04-05
45 citations
Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlle...
Todd M. Durell, Lenard A. Adler, Dave W. Williams, Ahmed Deldar, James J. McGough
Journal of Clinical Psychopharmacology. 2013-02-01
5 citations
Atomoxetine Increased Effect over Time in Adults with Attention-Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double-Blind, Placebo...
Linda Wietecha, David B. Clemow, Andrew S. Buchanan, Joel L. Young, Elias H. Sarkis
CNS Neuroscience & Therapeutics. 2016-07-01

Press Mentions

How to Support Employees Living with ADHDMarch 11th, 2021
How a Physician Treats ADHD with Combination TherapyAugust 6th, 2019